Clinical Outcomes and Prognostic Factors in Patients Undergoing Salvage Endoscopic Therapy for cT1N0M0 Local Failure After Chemoradiotherapy for Esophageal Cancer: A Multicenter Retrospective Study
Digestive Endoscopy · 2026
DOI: 10.1111/den.70033 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive Endoscopy, 2026. Verfasst von Keiichiro Nakajo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan. Hauptthemen laut MEDLINE: Salvage Therapy, Esophageal Neoplasms, Chemoradiotherapy, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Objectives
Salvage endoscopic therapy is increasingly recommended for localized, superficial failure at the primary site after chemoradiotherapy for esophageal squamous cell carcinoma. This multicenter retrospective study aimed to evaluate the clinical outcomes and prognostic factors associated with overall survival in patients who underwent salvage endoscopic therapy for cT1N0M0 local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
Methods
We retrospectively analyzed patients with cT1N0M0 local failure after chemoradiotherapy or radiotherapy who underwent endoscopic resection or photodynamic therapy using talaporfin sodium at two Japanese institutions between 2012 and 2021. Clinical outcomes and prognostic factors for overall survival were assessed using multivariate analysis.
Results
Complete resection was achieved in 63 of 84 patients (75%) who underwent endoscopic resection, and a local complete response was achieved in 50 of 81 patients (62%) who underwent photodynamic therapy. During a median follow‐up of 34 months (range, 2–109 months), 3‐year overall survival, disease‐specific survival, local recurrence‐free survival, and esophagectomy‐free survival rates were 79%, 88%, 54%, and 79%, respectively. A high Charlson Comorbidity Index (≥ 3; hazard ratio: 3.3) was significantly associated with poor overall survival (3‐year overall survival rate: 64%), although the 3‐year disease‐specific survival in this group remained high at 94%.
Conclusions
We clarified the clinical outcomes and prognosis of salvage endoscopic therapy for cT1 local failure. The Charlson Comorbidity Index may serve as a useful prognostic factor to aid in clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
- Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
ORCID-Profile: Atsushi Inaba, Tomohiro Kadota, Kensuke Shinmura, Tomonori Yano
Zitieren
APA
Nakajo, K., Minamide, T., Yamashita, H., Inaba, A., Sunakawa, H., Kadota, T., Shinmura, K., Ono, H., & Yano, T. (2026). Clinical Outcomes and Prognostic Factors in Patients Undergoing Salvage Endoscopic Therapy for cT1N0M0 Local Failure After Chemoradiotherapy for Esophageal Cancer: A Multicenter Retrospective Study. Digestive Endoscopy. https://doi.org/10.1111/den.70033
Vancouver
Nakajo K, Minamide T, Yamashita H, Inaba A, Sunakawa H, Kadota T, et al. Clinical Outcomes and Prognostic Factors in Patients Undergoing Salvage Endoscopic Therapy for cT1N0M0 Local Failure After Chemoradiotherapy for Esophageal Cancer: A Multicenter Retrospective Study. Digestive Endoscopy. 2026. doi:10.1111/den.70033
BibTeX
@article{Nakajo2026,
author = {Nakajo, Keiichiro and Minamide, Tatsunori and Yamashita, Hiroki and Inaba, Atsushi and Sunakawa, Hironori and Kadota, Tomohiro and Shinmura, Kensuke and Ono, Hiroyuki and Yano, Tomonori},
title = {Clinical Outcomes and Prognostic Factors in Patients Undergoing Salvage Endoscopic Therapy for cT1N0M0 Local Failure After Chemoradiotherapy for Esophageal Cancer: A Multicenter Retrospective Study},
journal = {Digestive Endoscopy},
year = {2026},
doi = {10.1111/den.70033}
}
EUVIMED